| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 25/11/2024 | 17:40 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:MLAB | Mesa Laboratories Inc |
| 07/11/2024 | 14:05 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NASDAQ:MLAB | Mesa Laboratories Inc |
| 07/11/2024 | 14:03 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:MLAB | Mesa Laboratories Inc |
| 07/11/2024 | 14:00 | GlobeNewswire Inc. | Mesa Labs Announces Second Quarter Results | NASDAQ:MLAB | Mesa Laboratories Inc |
| 29/10/2024 | 20:47 | Edgar (US Regulatory) | Form 144 - Report of proposed sale of securities | NASDAQ:MLAB | Mesa Laboratories Inc |
| 15/10/2024 | 19:29 | Edgar (US Regulatory) | Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] | NASDAQ:MLAB | Mesa Laboratories Inc |
| 02/10/2024 | 20:00 | GlobeNewswire Inc. | MESA LABS DECLARES QUARTERLY DIVIDEND | NASDAQ:MLAB | Mesa Laboratories Inc |
| 05/08/2024 | 14:00 | GlobeNewswire Inc. | Mesa Labs Announces First Quarter Results | NASDAQ:MLAB | Mesa Laboratories Inc |
| 19/07/2024 | 14:00 | Edgar (US Regulatory) | Form DEF 14A - Other definitive proxy statements | NASDAQ:MLAB | Mesa Laboratories Inc |
| 14/06/2024 | 15:44 | Edgar (US Regulatory) | Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 | NASDAQ:MLAB | Mesa Laboratories Inc |
| 05/06/2024 | 12:00 | GlobeNewswire Inc. | Mesa Labs Announces Fourth Quarter and Full Fiscal Year 2024 Results | NASDAQ:MLAB | Mesa Laboratories Inc |
| 31/05/2024 | 12:00 | GlobeNewswire Inc. | Mesa Laboratories, Inc. Revises Earnings Announcement date for Unaudited Fourth Quarter and Full Fiscal Year 2024 Results | NASDAQ:MLAB | Mesa Laboratories Inc |
| 24/05/2024 | 14:42 | IH Market News | U.S. Index Futures Show Pre-Market Gains, Oil Prices Fall | NASDAQ:MLAB | Mesa Laboratories Inc |
| 22/05/2024 | 12:00 | GlobeNewswire Inc. | Mesa Laboratories, Inc. Revises Earnings Announcement date for Unaudited Fourth Quarter and Full Fiscal Year 2024 Results to May 31, 2024 | NASDAQ:MLAB | Mesa Laboratories Inc |
| 08/04/2024 | 14:00 | GlobeNewswire Inc. | MESA LABS ANNOUNCES AMENDMENT TO CREDIT FACILITY AND REPURCHASE OF SENIOR CONVERTIBLE NOTES | NASDAQ:MLAB | Mesa Laboratories Inc |
| 01/04/2024 | 16:27 | GlobeNewswire Inc. | Mesa Laboratories, Inc. to Announce Unaudited Fourth Quarter and Full Fiscal Year 2024 Results on May 24, 2024 | NASDAQ:MLAB | Mesa Laboratories Inc |
| 15/03/2024 | 12:00 | GlobeNewswire Inc. | Mesa Labs Releases Second Annual Responsible Business Program Brochure | NASDAQ:MLAB | Mesa Laboratories Inc |
| 16/02/2024 | 17:37 | Edgar (US Regulatory) | Form 3 - Initial statement of beneficial ownership of securities | NASDAQ:MLAB | Mesa Laboratories Inc |
| 05/02/2024 | 14:00 | GlobeNewswire Inc. | Mesa Labs Announces Third Quarter Results | NASDAQ:MLAB | Mesa Laboratories Inc |
| 23/01/2024 | 20:18 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] | NASDAQ:MLAB | Mesa Laboratories Inc |
| 08/01/2024 | 14:00 | GlobeNewswire Inc. | Mesa Laboratories Appoints Mark Capone to its Board of Directors | NASDAQ:MLAB | Mesa Laboratories Inc |
| 03/01/2024 | 14:00 | GlobeNewswire Inc. | Mesa Labs Completes the Acquisition of GKE Science & Technology Co. | NASDAQ:MLAB | Mesa Laboratories Inc |
| 14/12/2023 | 16:47 | GlobeNewswire Inc. | Mesa Laboratories, Inc. to Announce Second Quarter Results on February 5, 2024 | NASDAQ:MLAB | Mesa Laboratories Inc |
| 16/10/2023 | 09:00 | GlobeNewswire Inc. | Mesa Labs Acquires GKE-GmbH Complementary Sterilization Indicators and Healthcare Channels to Mesa’s SDC Platform | NASDAQ:MLAB | Mesa Laboratories Inc |
| 13/09/2023 | 19:37 | GlobeNewswire Inc. | Mesa Laboratories, Inc. to Announce Second Quarter Results on November 6, 2023 | NASDAQ:MLAB | Mesa Laboratories Inc |
| 30/08/2023 | 20:36 | Edgar (US Regulatory) | Form S-8 - Securities to be offered to employees in employee benefit plans | NASDAQ:MLAB | Mesa Laboratories Inc |
| 24/08/2023 | 22:02 | GlobeNewswire Inc. | Mesa Laboratories, Inc. Announces Commitment to Disclose Scope 1 and 2 Greenhouse Gas Emissions | NASDAQ:MLAB | Mesa Laboratories Inc |
| 03/07/2023 | 16:27 | Edgar (US Regulatory) | Form PRE 14A - Other preliminary proxy statements | NASDAQ:MLAB | Mesa Laboratories Inc |
| 26/06/2023 | 16:46 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:MLAB | Mesa Laboratories Inc |
| 21/06/2023 | 17:50 | GlobeNewswire Inc. | Mesa Laboratories, Inc. to Announce First Quarter Results on August 3, 2023 | NASDAQ:MLAB | Mesa Laboratories Inc |